Merial acquiring animal health division of India's Dosch Pharmaceuticals

Merial, the animal health division of Sanofi, has announced that Sanofi has entered into a binding agreement to acquire the animal health division of Indian company Dosch Pharmaceuticals Private Limited, creating a market entry for Merial in that country’s growing animal health sector.

Merial, the animal health division of Sanofi, has announced that Sanofi has entered into a binding agreement to acquire the animal health division of Indian company Dosch Pharmaceuticals Private Limited, creating a market entry for Merial in that country’s growing animal health sector.

The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals. Products include animal health therapeutics and nutritional feed supplements. “The acquisition of Dosch’s animal health division will be a significant milestone for Merial and give us a strategic platform for our development in the Indian market,” said Jose Barella, CEO of Merial. “We are convinced that the combination of Dosch’s animal health brands and distribution strength, along with the robust new product pipelines from both Merial and Dosch, will strongly position Merial to become rapidly a major animal health player in India.”

The agreement is subject to regulatory approval and is expected to finalize sometime in the first half of 2013. Financial details were not disclosed.

 

 

Page 1 of 56
Next Page